IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA panel backs Pfizer COVID-19 booster shots for adults 65 and older


An FDA advisory committee overwhelmingly rejected recommending a third dose of Pfizer's COVID-19 vaccine for the general public but endorsed it for people 65 and older and those at high risk for illness. NBC’s Kathy Park reports for Weekend TODAY.